362 related articles for article (PubMed ID: 28132922)
41. Individualized Perioperative Blood Pressure Management for Adult Moyamoya Disease: Experience from 186 Consecutive Procedures.
Li C; Zhang N; Yu S; Xu Y; Yao Y; Zeng M; Li D; Xia C
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105413. PubMed ID: 33160127
[TBL] [Abstract][Full Text] [Related]
42. Moyamoya disease presenting with subarachnoid hemorrhage: Clinical features and neuroimaging of a case series.
Wan M; Han C; Xian P; Yang WZ; Li DS; Duan L
Br J Neurosurg; 2015; 29(6):804-10. PubMed ID: 26313681
[TBL] [Abstract][Full Text] [Related]
43. Hemorrhagic Moyamoya Disease in Children: Clinical, Angiographic features, and Long-Term Surgical Outcome.
Liu P; Han C; Li DS; Lv XL; Li YX; Duan L
Stroke; 2016 Jan; 47(1):240-3. PubMed ID: 26534975
[TBL] [Abstract][Full Text] [Related]
44. Familial occurrence of moyamoya disease: a clinical study.
Seol HJ; Wang KC; Kim SK; Hwang YS; Kim KJ; Cho BK
Childs Nerv Syst; 2006 Sep; 22(9):1143-8. PubMed ID: 16565850
[TBL] [Abstract][Full Text] [Related]
45. Postoperative Cerebral Infarction Risk Factors and Postoperative Management of Pediatric Patients with Moyamoya Disease.
Muraoka S; Araki Y; Kondo G; Kurimoto M; Shiba Y; Uda K; Ota S; Okamoto S; Wakabayashi T
World Neurosurg; 2018 May; 113():e190-e199. PubMed ID: 29432946
[TBL] [Abstract][Full Text] [Related]
46. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.
Li J; Zhao Y; Zhao M; Cao P; Liu X; Ren H; Zhang D; Zhang Y; Wang R; Zhao J
Neurosurg Rev; 2020 Apr; 43(2):759-769. PubMed ID: 31203482
[TBL] [Abstract][Full Text] [Related]
47. Failures in Revascularization for Pediatric Moyamoya Disease and Syndrome: A Scoping Review.
Shlobin NA; Frankel HG; Lam S
World Neurosurg; 2021 May; 149():204-214.e1. PubMed ID: 33618047
[TBL] [Abstract][Full Text] [Related]
48. Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.
Wang X; Zhang Z; Wang Y; Zou Z; Ta N; Hao F; Shang M; Li D; Zeng F; Han C; Nie F; Bao X; Yang Y; Wang H; Liang M; Yang R; Ou L; Wen L; Yang Z; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105847. PubMed ID: 33992965
[TBL] [Abstract][Full Text] [Related]
49. Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome.
Choi JW; Chong S; Phi JH; Lee JY; Kim HS; Chae JH; Lee J; Kim SK
World Neurosurg; 2020 Apr; 136():e158-e164. PubMed ID: 31870818
[TBL] [Abstract][Full Text] [Related]
50. [Long-term Outcome over Five Years after Surgical Revascularization in Adult Moyamoya Disease].
Ozaki S; Inoue A; Miyazaki H; Onoue S; Ichikawa H; Fukumoto S; Iwata S; Ohue S; Kohno K
No Shinkei Geka; 2016 Oct; 44(10):823-834. PubMed ID: 27729602
[TBL] [Abstract][Full Text] [Related]
51. Operative wound-related complications after cranial revascularization surgeries.
Takanari K; Araki Y; Okamoto S; Sato H; Yagi S; Toriyama K; Yokoyama K; Murotani K; Matsui S; Wakabayashi T; Kamei Y
J Neurosurg; 2015 Nov; 123(5):1145-50. PubMed ID: 26140494
[TBL] [Abstract][Full Text] [Related]
52. Risk factors and a novel cerebral infarction extent scoring system for postoperative cerebral ischemia in patients with ischemic Moyamoya disease.
Chen Y; Gong X; Yang Z; Chen F; Wang J
Sci Rep; 2023 Apr; 13(1):5726. PubMed ID: 37029162
[TBL] [Abstract][Full Text] [Related]
53. A long-term study of posterior circulation changes after revascularization in patients with moyamoya disease.
Bao XY; Tong HY; Wang QN; Wang XP; Gao G; Zhang Q; Zou ZX; Duan L
J Neurosurg; 2023 Nov; 139(5):1281-1286. PubMed ID: 37029668
[TBL] [Abstract][Full Text] [Related]
54. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
55. Clinical course of asymptomatic adult moyamoya disease.
Jo KI; Yeon JY; Hong SC; Kim JS
Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
[TBL] [Abstract][Full Text] [Related]
56. Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease.
Funaki T; Takahashi JC; Takagi Y; Yoshida K; Araki Y; Kikuchi T; Kataoka H; Iihara K; Miyamoto S
J Neurosurg Pediatr; 2013 Dec; 12(6):626-32. PubMed ID: 24138143
[TBL] [Abstract][Full Text] [Related]
57. Risk Factors for Epilepsy Recurrence after Revascularization in Pediatric Patients with Moyamoya Disease.
Ma Y; Zhao M; Zhang Q; Liu X; Zhang D; Wang S; Zhang Y; Li M; Zhao J
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):740-746. PubMed ID: 29128331
[TBL] [Abstract][Full Text] [Related]
58. The natural clinical course of hemodynamically stable adult moyamoya disease.
Cho WS; Chung YS; Kim JE; Jeon JP; Son YJ; Bang JS; Kang HS; Sohn CH; Oh CW
J Neurosurg; 2015 Jan; 122(1):82-9. PubMed ID: 25361479
[TBL] [Abstract][Full Text] [Related]
59. Headache in Pediatric Moyamoya Disease after Revascularization Surgery.
Yang J; Kim SK; Chu MK; Rho YI; Phi JH; Lee SY
Cerebrovasc Dis; 2023; 52(3):266-274. PubMed ID: 36944315
[TBL] [Abstract][Full Text] [Related]
60. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
